ACE rs4291: Understanding This Genetic Variant
The rs4291 variant is a single nucleotide polymorphism located within the ACE gene, which encodes the angiotensin-converting enzyme. Research has explored its potential associations with blood pressure regulation and individual responses to certain antihypertensive medications.
What each genotype means
Typical ACE activity baseline
Carriers of the AA genotype have the typical baseline for this genetic locus within the ACE gene. While some pharmacogenetic studies link this genotype to lower odds of blood pressure control on certain renin-angiotensin medications compared to T-allele carriers, the overall clinical evidence remains limited and conflicting. Please discuss any blood pressure medication choices or dosage adjustments directly with your clinician or pharmacist.
Carried by approximately 25% to 40% of individuals globally, depending on geographic ancestry.
Intermediate medication response profile
Carrying one copy of the T allele has been linked in limited studies to variable antihypertensive responses, including enhanced blood pressure reduction with losartan in some cohorts but altered responses to other agents in others. Because the clinical evidence is mixed and strongly influenced by ancestry and other genetic variants, this genotype does not determine medical outcomes on its own. Any adjustments to antihypertensive therapy should be discussed with your prescribing physician or pharmacist.
Found in approximately 40% to 50% of individuals across diverse global populations.
Altered blood pressure response
Carrying two copies of the T allele has been associated in preliminary research with differences in ACE enzyme activity and variable responses to blood pressure drugs such as ACE inhibitors and receptor blockers. However, published findings are limited, inconsistent across ancestries, and not currently incorporated into clinical practice guidelines. You should consult your healthcare provider or pharmacist regarding any medication efficacy or dosing questions.
Found in roughly 10% to 25% of individuals worldwide, with frequency varying across ethnic groups.
What is rs4291?
The rs4291 variant is a specific genetic change, or single nucleotide polymorphism (SNP), found within the ACE gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. The ACE gene provides instructions for making the angiotensin-converting enzyme, a critical component of the renin-angiotensin-aldosterone system (RAAS). This system is a complex hormonal pathway that plays a primary role in regulating blood pressure and fluid balance in the body. Because rs4291 is located within this gene, researchers have long investigated whether this specific variation influences the production or activity levels of the ACE enzyme, potentially impacting how an individual's body manages cardiovascular health.
The Role of the ACE Gene
The ACE gene is responsible for producing the angiotensin-converting enzyme. This enzyme acts as a key regulator by converting angiotensin I into angiotensin II, a potent hormone that causes blood vessels to constrict, thereby increasing blood pressure. By modulating this pathway, the ACE gene is central to cardiovascular homeostasis. Because of its influence on blood pressure, the ACE gene is a frequent target for pharmacological intervention. ACE inhibitors are a common class of medications used to treat hypertension and heart failure by blocking the activity of this enzyme. Genetic variations within the ACE gene, such as rs4291, are studied to determine if they contribute to the natural variability in enzyme levels or if they influence how effectively a patient responds to these specific blood pressure-lowering drugs.
Research and Evidence Strength
Evidence linking rs4291 to clinical outcomes is currently considered limited and mixed. Some studies have suggested that certain genotypes may be associated with differences in blood pressure response to ACE inhibitors or other antihypertensive agents. For example, research has explored whether specific alleles correlate with better blood pressure control in patients treated with losartan. Other studies have investigated potential links between rs4291 and conditions like hypertension or renal function, with varying results across different populations. It is important to note that many of these findings are based on observational studies with relatively small sample sizes. Consequently, while rs4291 is a subject of ongoing pharmacogenetic interest, it is not currently a primary marker used in standard clinical guidelines for dosing medications. Further large-scale research is required to clarify its clinical significance.
Population Frequency
The frequency of the rs4291 variant is known to be highly variable across different ancestral groups. Studies comparing diverse populations, such as Indigenous Australians and non-Indigenous groups, have demonstrated significant differences in the prevalence of the A and T alleles. Because allele frequencies are not uniform globally, the distribution of genotypes (AA, AT, and TT) differs substantially depending on an individual's genetic background. This variability underscores the importance of considering ancestry when interpreting genetic data, as a genotype that is common in one population may be rare in another.
What You Can Do With This Information
Genetic information regarding variants like rs4291 is intended for educational purposes and should not be used to make personal medical decisions. Because the evidence for this variant is limited and does not currently guide standard clinical practice, it cannot be used to predict your specific response to medication or to diagnose a health condition. If you have questions about your blood pressure management or the medications you are taking, the most important step is to consult with your healthcare provider or a pharmacist. They can evaluate your clinical history, current health status, and established medical guidelines to provide appropriate care. Never change your medication regimen based on genetic test results without professional medical supervision.
How common is this variant?
The frequency of the rs4291 alleles varies significantly by ancestry, with studies showing distinct distribution patterns between different ethnic and geographic populations.
Frequently asked questions
Can rs4291 predict if my blood pressure medication will work?
Currently, there is no strong clinical evidence to suggest that rs4291 can reliably predict how an individual will respond to blood pressure medication. While some research studies have explored this, it is not used in standard clinical practice for medication selection or dosing.
Is rs4291 a diagnostic test for hypertension?
No, rs4291 is not a diagnostic test for hypertension. Hypertension is a complex condition influenced by many genetic and environmental factors, and this single variant does not provide a diagnosis.
Should I change my medication based on my rs4291 genotype?
You should never change your medication based on genetic test results without consulting your doctor. Always discuss any concerns about your treatment plan with your healthcare provider or pharmacist.
Where can I find more information about ACE gene variants?
You can find reliable information through resources like MedlinePlus Genetics or by searching for the ACE gene on the National Center for Biotechnology Information (NCBI) website. These platforms provide scientifically grounded information on gene functions and known variants.
Sources & further reading
Educational information only, last refreshed 10/24/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4291?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ACE
The ACE I/D polymorphism (rs1799752) is associated with circulating ACE activity, physical performance, and ACE inhibitor-induced cough.
Exonic variant in ACE often used as a proxy for the ACE insertion/deletion polymorphism affecting circulating ACE enzyme activity.
This variant in the ACE gene is associated with variations in soluble amyloid-beta levels in patients with Alzheimer's disease.
This SNP is being investigated as a potential biomarker for personalized antihypertensive therapy in specific ethnic cohorts.
A variant recently evaluated in pharmacogenomic studies of the Pashtun population to assess its role in antihypertensive drug response.
Coding-region single nucleotide variant in the angiotensin-converting enzyme gene investigated for modulation of baseline exercise test duration and cardiovascular training response.